NASDAQ:FLXN - Flexion Therapeutics Price Target & Analyst Ratings

$11.50
+0.61 (+5.60 %)
(As of 06/17/2019 03:13 PM ET)
Today's Range
$10.62
Now: $11.50
$11.51
50-Day Range
$10.21
MA: $11.70
$13.35
52-Week Range
$9.65
Now: $11.50
$29.10
Volume21,484 shs
Average Volume445,370 shs
Market Capitalization$436.89 million
P/E RatioN/A
Dividend YieldN/A
Beta1.4

Analyst Ratings

Flexion Therapeutics (NASDAQ:FLXN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Flexion Therapeutics in the last 12 months. Their average twelve-month price target is $25.50, suggesting that the stock has a possible upside of 121.74%. The high price target for FLXN is $36.00 and the low price target for FLXN is $18.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.803.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $25.50$25.50$25.4980$39.00
Price Target Upside: 121.74% upside163.43% upside71.13% upside139.12% upside

Flexion Therapeutics (NASDAQ:FLXN) Consensus Price Target History

Price Target History for Flexion Therapeutics (NASDAQ:FLXN)

Flexion Therapeutics (NASDAQ:FLXN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/9/2019Northland SecuritiesReiterated RatingBuy$20.00HighView Rating Details
5/9/2019BenchmarkUpgradeHold ➝ Buy$19.00HighView Rating Details
4/11/2019LaidlawSet Price TargetBuy$18.00LowView Rating Details
4/10/2019Wells Fargo & CoReiterated RatingBuyLowView Rating Details
3/28/2019Raymond JamesReiterated RatingBuyHighView Rating Details
1/4/2019BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$36.00 ➝ $34.00HighView Rating Details
1/4/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$42.00 ➝ $36.00HighView Rating Details
2/1/2018Berenberg BankInitiated CoverageBuy$42.00HighView Rating Details
10/29/2017Royal Bank of CanadaSet Price TargetBuy$44.00N/AView Rating Details
10/10/2017Janney Montgomery ScottBoost Price TargetBuy ➝ Fair Value$570.00N/AView Rating Details
(Data available from 6/17/2017 forward)
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel